Document is current
Any future updates will be listed below
-
Authors
Jeong, Jinyoung
Jo, Hyesu
Son, Yejun
Park, Jaeyu
Oh, Jiyeon
Lee, Sooji
Jeong, Yi Deun
Lee, Kyeongmin
Kim, Hyeon Jin
Lee, Hayeon
Kim, Soeun
Yim, Yesol
Rahmati, Masoud
Kang, Jiseung
Udeh, Raphael
Pizzol, Damiano
Smith, Lee
Hwang, Jiyoung
Yon, Dong Keon
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2024-00460379)
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 9 April 2025
First Online: 17 April 2025
Declarations
:
: The authors declare no competing interests.
: Owing to the absence of identifiable personal data regarding patients or reporters in the WHO international pharmacovigilance database, informed consent was not required. Patient consent was not required as this study was based on publicly available data. Ethics approval was not required for this study, as the research involved anonymized data. This study protocol was reviewed and approved by Kyung Hee University and the Uppsala Monitoring Centre. Furthermore, as this study is based on population-level data, ethical approval and informed consent were not required. The study was conducted in accordance with relevant guidelines and regulations.
